RASHMI KRISHNA MURTHY to Germ-Line Mutation
This is a "connection" page, showing publications RASHMI KRISHNA MURTHY has written about Germ-Line Mutation.
Connection Strength
0.066
-
Survival outcomes of patients with HER2/neu-positive breast cancer with germline BRCA mutations. Cancer. 2024 May 01; 130(9):1600-1608.
Score: 0.038
-
Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant. J Clin Oncol. 2020 02 10; 38(5):388-394.
Score: 0.028